Close

New MS PATHS Data at ECTRIMS 2021 Confirm Biogen’s Disease-Modifying Therapies Do Not Reduce Antibody Response to COVID-19 Vaccines in People with Multiple Sclerosis

Go back to New MS PATHS Data at ECTRIMS 2021 Confirm Biogen’s Disease-Modifying Therapies Do Not Reduce Antibody Response to COVID-19 Vaccines in People with Multiple Sclerosis
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 215.63 -0.71 (0.33%)
Previous Close $216.34    52 Week High $333.65 
Open $217.36    52 Week Low $223.02 
Day High $215.71    P/E 27.61 
Day Low $215.71    EPS $7.81 
Volume 1,912,277